Description
LL-37 5 mg | Pure Lab Peptides Supply
Buy LL-37 5 mg from Pure Lab Peptides Supply. Each vial contains 5 mg of labeled research material in lyophilized powder form. This presentation supports laboratory research, peptide characterization, and analytical reference purposes.
Product Overview
LL-37 is a 37-amino-acid peptide derived from the C-terminal region of the human cathelicidin precursor protein, hCAP18. It belongs to the cathelicidin family of antimicrobial peptides and is widely studied in innate immune research.
The peptide has a defined amino acid sequence that contributes to its molecular structure and physicochemical properties. Furthermore, researchers investigate LL-37 in experimental models involving antimicrobial activity, host-defense signaling, and immune-related cellular processes.
Pure Lab Peptides Supply offers LL-37 in a 5 mg presentation. Moreover, the lyophilized format provides a dry material form for laboratory inventory and appropriate storage. Importantly, the stated 5 mg represents the labeled mass of the material, not a concentration or prepared solution volume.
Product Information
| Specification | Details |
|---|---|
| Product name | LL-37 |
| Alternative designation | Human cathelicidin antimicrobial peptide |
| Precursor protein | hCAP18 |
| Compound class | Antimicrobial peptide |
| Peptide length | 37 amino acid residues |
| Labeled quantity | 5 mg |
| Presentation | One vial |
| Physical format | Lyophilized powder |
| Source classification | Human cathelicidin-derived sequence |
| Product type | Research material |
| Intended application | Laboratory research and analytical reference |
| Documentation | Online COA access |
Molecular Characteristics
LL-37 has a defined 37-residue amino acid sequence. Its commonly referenced structure contains an unmodified N-terminus and a free C-terminal carboxyl group.
The following reference specifications describe the commonly reported human LL-37 structure:
- CAS number: 154947-66-7
- Molecular formula: C₂₀₅H₃₄₀N₆₀O₅₃
- Molecular weight: Approximately 4,493.37 g/mol
- Amino acid sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
- Peptide length: 37 amino acid residues
- Structural classification: Linear peptide
- Terminal structure: Free N-terminus and free C-terminus in the commonly referenced structure
These specifications describe the standard LL-37 reference sequence. However, the exact chemical form and terminal modifications should match the supplied material’s product specification. Therefore, researchers should consult the applicable product documentation and batch COA when confirming molecular identity.
Understanding the LL-37 Research Classification
LL-37 is part of the cathelicidin family of host-defense peptides. The name refers to its 37-amino-acid length and its characteristic N-terminal leucine-leucine residues.
Researchers study LL-37 because of its structural and physicochemical characteristics. In particular, its sequence contains numerous positively charged amino acid residues, which contribute to its cationic character.
Furthermore, LL-37 is commonly investigated in experimental research involving:
- Antimicrobial peptide structure and activity
- Host-defense and innate immune signaling
- Peptide interactions with biological membranes
- Inflammatory signaling pathways
- Peptide stability and molecular characterization
These areas describe research topics rather than established clinical outcomes. Consequently, LL-37 should be identified by its molecular structure and research classification rather than presented as a treatment or therapeutic product.
Why Choose the LL-37 5 mg Presentation?
The 5 mg presentation provides a clearly labeled quantity for laboratory inventory and material identification. In addition, the single-vial format helps researchers organize LL-37 alongside other peptide research materials.
The lyophilized format offers a dry material presentation for appropriate laboratory storage. Moreover, the defined label quantity supports straightforward product identification when maintaining research records.
Nevertheless, the labeled quantity alone does not establish purity, identity, or analytical performance. For this reason, researchers should review the applicable batch documentation before making material comparisons.
Quality Documentation and COA
Product documentation helps researchers verify material identity and review available analytical information. For this reason, Pure Lab Peptides Supply provides access to its COA documentation page.
Visit the Pure Lab Peptides Supply COA page to review available documentation.
When reviewing a COA, check the product identifier and batch information carefully. Furthermore, compare the reported analytical results with the relevant product specifications. For LL-37, molecular mass and sequence identity provide useful reference points. However, the analytical method must be appropriate for the specific identity and purity characteristics being assessed.
Discreet Delivery with Pure Lab Peptides Supply
Pure Lab Peptides Supply prioritizes professional order handling and discreet presentation. To support customer privacy, eligible shipments use odor-proof, tamper-resistant, non-branded packaging.
Additionally, eligible orders include tracking information so customers can follow shipment progress. The exterior packaging avoids unnecessary product details. As a result, customers receive a professional and privacy-focused delivery experience.
Storage and Handling
LL-37 arrives as lyophilized powder. Therefore, follow the storage conditions stated in the applicable product documentation and COA.
Keep the vial properly sealed and protect the material from unsuitable environmental conditions. In addition, follow established laboratory handling procedures and applicable institutional requirements.
Storage recommendations can vary with formulation and packaging. Consequently, consult the accompanying product documentation rather than assume that one storage condition applies to every LL-37 preparation.
Frequently Asked Questions
What is LL-37?
LL-37 is a 37-amino-acid peptide derived from the human cathelicidin precursor protein hCAP18. It belongs to the cathelicidin family and is studied in antimicrobial peptide and innate immune research.
What does the name LL-37 mean?
The name reflects the peptide’s 37-amino-acid length and its two initial leucine residues. This naming convention distinguishes it within the cathelicidin research family.
What is the amino acid sequence of LL-37?
The commonly reported sequence is LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES. It contains 37 amino acid residues.
How much material does each vial contain?
Each vial carries a labeled quantity of 5 mg of dry research material. This figure represents material mass rather than solution concentration.
What is the molecular weight of LL-37?
The commonly reported molecular weight is approximately 4,493.37 g/mol. Nevertheless, researchers should confirm the chemical form and analytical identity of the supplied material through its applicable documentation.
What is the physical format?
Pure Lab Peptides Supply offers LL-37 5 mg as lyophilized powder in one vial.
Is LL-37 the same as hCAP18?
No. hCAP18 is the human cathelicidin precursor protein, while LL-37 is the 37-amino-acid peptide fragment released from its C-terminal region.
Where can I find COA documentation?
Visit the Pure Lab Peptides Supply COA page to access available documentation. Always check the relevant product and batch details when reviewing analytical information.
Order LL-37 5 mg
Explore the LL-37 5 mg listing at Pure Lab Peptides Supply. Each presentation contains one vial of lyophilized research material with a labeled quantity of 5 mg.
For additional product information, review the available documentation and COA resources. This way, you can compare the stated product specifications with the relevant analytical records.

















